Market Expectations Leave Little Cushion
Fair valueDCF
Equity analysis

HCA Healthcare Inc (HCA) Market Expectations Leave Little Cushion

Apr 2, 2026Equity Analysis

Is the market pricing in too much reinvestment success?

Trailing P/E
15.65
Price
467.81
ROE
695.73
Gross Margin
84.96

How Does This Hospital Network Operate?

HCA Healthcare runs hospitals and delivers a broad set of health care services through its facility network. The business is built around providing acute care and related patient services at scale. Its footprint and operating model are geared toward high-throughput, high-complexity care delivery. The company’s size also makes ongoing spending on facilities and equipment a core part of how it operates.

Are Margins Holding Up With Growth?

Fundamentals

For 2025, reported in USD, revenue was about USD 75.6 billion, alongside net income of roughly USD 7.8 billion. Over the same period, revenue grew 7.1% year over year, with trailing margins showing 15.83% at the operating line and 8.97% at the bottom line.

Reinvestment remained a visible part of the financial profile, with depreciation and amortization of about USD 3.5 billion and capital spending of roughly USD 4.9 billion. Cash ended the period at around USD 1.0 billion, while total debt stood near USD 9.8 billion.

Is The Stock Fully Valued Now?

DCF / Multiples

At about USD 467.81, the stock sits essentially on the central DCF estimate, with the valuation range running from roughly USD 267 in a weaker scenario to about USD 469 at the midpoint and around USD 684 in a stronger outcome. The pricing also lines up with a 15.65 P/E and 9.77 EV/EBITDA on a trailing basis.

A Balanced But Demanding Setup

Takeaway

The price is already aligned with a midrange cash-flow outcome. For the case to work, reinvestment has to keep paying back. Capex cannot drift higher without matching profit growth. A slip in margins would tighten the room for spending. The setup looks balanced, not forgiving.

Disclaimer
This information is for general informational purposes only and is not investment advice.
Fair Value Rankings

Market Price vs Intrinsic Value

Quick access to the most undervalued and overvalued stocks, ranked by their discount or premium to DCF-based fair value.

Undervalued

Stocks trading below fair value

View full ranking
1
Delta Air Lines Inc
DAL
+80%
discount
2
Brown & Brown Inc
BRO
+79%
discount
3
Verizon Communications Inc
VZ
+78%
discount
Overvalued

Stocks trading above fair value

View full ranking
1
Bank of America Corp
BAC
+393%
premium
2
Applied Materials Inc
AMAT
+392%
premium
3
Guidewire Software Inc
GWRE
+391%
premium
INDEX
VDIX
ValueDetect Intrinsic eXpectations Index
Overvalued market
View index

VDIX measures whether the market is expensive or cheap relative to intrinsic value. For each company, ValueDetect estimates fair value using a discounted cash flow (DCF) model, then compares it with the current share price to derive a RiskRatio. These signals are capped, weighted by market capitalization, and aggregated into a single market-wide score.

Current score-0.82Negative = market trades above fair value
1-day move-0.13Rising score = improving valuation conditions
7-day average-0.68Smoothed market valuation signal
Latest observation03 June 2026The latest weighted reading suggests that the market is trading above DCF-based intrinsic value in aggregate.
Next actions

What would you like?

Continuously expanding company coverage — prioritized by user demand.

Suggest a company to analyze

Help shape what we analyze next.

We'll send a confirmation email to verify your request — not for marketing.

New analyses are added regularly. Request processing times may vary.